|
ASX - By Stock
|
CBE |
Re:
Ann: Trading Halt
|
|
Aviza2913
|
23 |
4.3K |
0 |
09/02/26 |
| 09/02/26 |
ASX - By Stock
|
23
|
4.3K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Oral OA Animal Therapy Progresses via AVet Deal
|
|
Aviza2913
|
22 |
5.4K |
3 |
09/02/26 |
| 09/02/26 |
ASX - By Stock
|
22
|
5.4K
|
3
|
|
|
ASX - By Stock
|
PAR |
Re:
Is it more about BMELs than Cartilage?
|
|
Aviza2913
|
9 |
1.8K |
2 |
08/02/26 |
| 08/02/26 |
ASX - By Stock
|
9
|
1.8K
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
Aviza2913
|
70 |
13K |
4 |
07/02/26 |
| 07/02/26 |
ASX - By Stock
|
70
|
13K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
Aviza2913
|
70 |
13K |
3 |
05/02/26 |
| 05/02/26 |
ASX - By Stock
|
70
|
13K
|
3
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
Aviza2913
|
70 |
13K |
6 |
04/02/26 |
| 04/02/26 |
ASX - By Stock
|
70
|
13K
|
6
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
Aviza2913
|
15 |
3.1K |
5 |
04/02/26 |
| 04/02/26 |
ASX - By Stock
|
15
|
3.1K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Upcoming Expiry of PAROA Listed Options
|
|
Aviza2913
|
61 |
15K |
4 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
61
|
15K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Upcoming Expiry of PAROA Listed Options
|
|
Aviza2913
|
61 |
15K |
2 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
61
|
15K
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
2 |
01/02/26 |
| 01/02/26 |
ASX - By Stock
|
71
|
13K
|
2
|
|
|
ASX - By Stock
|
BTR |
Re:
Ann: Trading Halt
|
|
Aviza2913
|
81 |
22K |
4 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
81
|
22K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
4 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
71
|
13K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
0 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
71
|
13K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
7 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
71
|
13K
|
7
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
0 |
31/01/26 |
| 31/01/26 |
ASX - By Stock
|
71
|
13K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: December 2025 Quarterly Activities Report & Appendix 4C
|
|
Aviza2913
|
71 |
13K |
4 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
71
|
13K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 3 Knee OA Trial Recruitment Update
|
|
Aviza2913
|
56 |
17K |
18 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
56
|
17K
|
18
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
Aviza2913
|
4 |
1.0K |
0 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
4
|
1.0K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Section 507, DDT and the not so Binary Play?
|
|
Aviza2913
|
25 |
5.9K |
1 |
23/01/26 |
| 23/01/26 |
ASX - By Stock
|
25
|
5.9K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Section 507, DDT and the not so Binary Play?
|
|
Aviza2913
|
25 |
5.9K |
5 |
23/01/26 |
| 23/01/26 |
ASX - By Stock
|
25
|
5.9K
|
5
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Aviza2913
|
5.1K |
4.2M |
2 |
16/01/26 |
| 16/01/26 |
ASX - By Stock
|
5.1K
|
4.2M
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Aviza2913
|
5.1K |
4.2M |
1 |
14/01/26 |
| 14/01/26 |
ASX - By Stock
|
5.1K
|
4.2M
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Upcoming Expiry of PAROA Listed Options
|
|
Aviza2913
|
61 |
15K |
15 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
61
|
15K
|
15
|
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Biopharma rolls into CY26 on patient tailwinds after hitting 25% recruitment milestone
|
|
Aviza2913
|
31 |
7.9K |
10 |
05/01/26 |
| 05/01/26 |
ASX - By Stock
|
31
|
7.9K
|
10
|
|
|
ASX - By Stock
|
CSL |
Re:
Why is CSL tanking
|
|
Aviza2913
|
768 |
348K |
17 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
768
|
348K
|
17
|
|
|
ASX - By Stock
|
CSL |
Re:
CSL peer perspectives
|
|
Aviza2913
|
12 |
3.4K |
33 |
27/12/25 |
| 27/12/25 |
ASX - By Stock
|
12
|
3.4K
|
33
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Aviza2913
|
5.1K |
4.2M |
2 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
5.1K
|
4.2M
|
2
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 3 Knee OA Trial Recruitment Update
|
|
Aviza2913
|
56 |
17K |
8 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
56
|
17K
|
8
|
|
|
ASX - By Stock
|
CSL |
Re:
Dead cat bounce
|
|
Aviza2913
|
88 |
32K |
0 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
88
|
32K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
What is the reason for continued delay in trial site activation?
|
|
Aviza2913
|
12 |
2.5K |
3 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
12
|
2.5K
|
3
|
|
|
ASX - By Stock
|
CBE |
Re:
Okavango Target Drilling
|
|
Aviza2913
|
157 |
29K |
0 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
157
|
29K
|
0
|
|
|
ASX - By Stock
|
CBE |
Re:
Okavango Target Drilling
|
|
Aviza2913
|
157 |
29K |
0 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
157
|
29K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2025 AGM Chair Address and Presentation
|
|
Aviza2913
|
156 |
33K |
17 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
156
|
33K
|
17
|
|
|
ASX - By Stock
|
PAR |
Re:
Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie
|
|
Aviza2913
|
85 |
17K |
4 |
15/12/25 |
| 15/12/25 |
ASX - By Stock
|
85
|
17K
|
4
|
|
|
ASX - By Stock
|
PAR |
Re:
Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie
|
|
Aviza2913
|
85 |
17K |
9 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
85
|
17K
|
9
|
|
|
ASX - By Stock
|
PAR |
Re:
Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie
|
|
Aviza2913
|
85 |
17K |
13 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
85
|
17K
|
13
|
|
|
ASX - By Stock
|
PAR |
Re:
Expanding Horizons - The AI response
|
|
Aviza2913
|
40 |
12K |
0 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
40
|
12K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2025 AGM Chair Address and Presentation
|
|
Aviza2913
|
156 |
33K |
7 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
156
|
33K
|
7
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2025 AGM Chair Address and Presentation
|
|
Aviza2913
|
156 |
33K |
12 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
156
|
33K
|
12
|
|
|
ASX - By Stock
|
PAR |
Re:
The virtually impossible copy cat
|
|
Aviza2913
|
40 |
7.2K |
6 |
02/12/25 |
| 02/12/25 |
ASX - By Stock
|
40
|
7.2K
|
6
|
|
|
ASX - By Stock
|
PAR |
Re:
The virtually impossible copy cat
|
|
Aviza2913
|
40 |
7.2K |
0 |
02/12/25 |
| 02/12/25 |
ASX - By Stock
|
40
|
7.2K
|
0
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Aviza2913
|
5.1K |
4.2M |
10 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
5.1K
|
4.2M
|
10
|
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Step-Out Hole - Strike Continuity - High-Grade Cu - Cosmos
|
|
Aviza2913
|
233 |
42K |
2 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
233
|
42K
|
2
|
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Step-Out Hole - Strike Continuity - High-Grade Cu - Cosmos
|
|
Aviza2913
|
233 |
42K |
1 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
233
|
42K
|
1
|
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Step-Out Hole - Strike Continuity - High-Grade Cu - Cosmos
|
|
Aviza2913
|
233 |
42K |
0 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
233
|
42K
|
0
|
|
|
ASX - By Stock
|
ATR |
Re:
Ann: AGM - Chairman's Address to Shareholders
|
|
Aviza2913
|
3 |
1.6K |
1 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
3
|
1.6K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Aviza2913
|
5.1K |
4.2M |
7 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
5.1K
|
4.2M
|
7
|
|
|
ASX - By Stock
|
PAR |
Re:
It's like it was just written for us?
|
|
Aviza2913
|
48 |
12K |
6 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
48
|
12K
|
6
|
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Step-Out Hole - Strike Continuity - High-Grade Cu - Cosmos
|
|
Aviza2913
|
233 |
42K |
1 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
233
|
42K
|
1
|
|
|
ASX - By Stock
|
CBE |
Re:
Ann: Step-Out Hole - Strike Continuity - High-Grade Cu - Cosmos
|
|
Aviza2913
|
233 |
42K |
5 |
27/11/25 |
| 27/11/25 |
ASX - By Stock
|
233
|
42K
|
5
|
|